3SBio and DaVita Announce $20 Million Dialysis JV for China

3SBio will form a $20 million JV with DaVita Inc., a US-based company that owns and operates kidney dialysis clinics. The JV will provide dialysis services to Jilin and Liaoning provinces in northeast China. DaVita will contribute 70% of the start-up capital and 3SBio will be responsible for the remainder. As part of the agreement, the JV will use 3SBio’s EPAIO, a recombinant human erythropoietin, to treat the anemia that is often a side-effect of dialysis. More details.... Stock Symbols: (NSDQ: SSRX) (NYSE: DVA) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});